Patents
Literature
Patsnap Copilot is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Patsnap Copilot

61results about How to "Increase blood perfusion" patented technology

Closed-loop automatic external chest compression control system capable of adaptively adjusting external chest compression depth

InactiveCN108279565AReal-time monitoring of physiological statusIncrease compression depthElectrotherapyAdaptive controlControl systemClosed loop
The invention discloses a closed-loop automatic external chest compression control system capable of adaptively adjusting the external chest compression depth. The system comprises an input saturationprocessing module used for carrying out input saturation treatment on signals PETCO2 and Kchest after the band-pass filtering process, wherein the processed signals reflect the blood perfusion degreeand the fracture risk of a current patient, a fuzzy control module used for calculating to obtain a pressing depth adjusting increment according to the processed signals; an output saturation processing module used for carrying out optimization treatment on the pressing depth adjusting increment and outputting the optimized pressing depth adjusting increment; and a fuzzy PID automatic adjustmentmodule used for automatically adjusting the pressing depth of an external chest compression device according to the optimized pressing depth adjusting increment, and carrying out automatic external chest compression according to a target pressing depth value. According to the embodiments of the invention, based on the above design, the physiological status of a patient can be monitored in real time during the automatic external chest compression process. Meanwhile, the external chest compression depth can be automatically adjusted according to the physiological status of the patient. As a result, the safety of external chest compression is improved, and the better blood perfusion effect is achieved.
Owner:SANITARY EQUIP INST ACAD OF MILITARY MEDICAL SCI PLA

Fumailing capsule for preventing and treating slow arrhythmia and preparation method of Fumailing capsule

The invention discloses a Fumailing capsule for preventing and treating slow arrhythmia and a preparation method of the Fumailing capsule. The capsule is prepared from the following traditional Chinese medicinal materials: 8-12g of ephedra, 8-10g of aconite roots, 2-4g of asarum herb, 25-32g of prepared liquorice roots, 10-14g of radix ginseng, 10-12g of ramulus cinnamomi, 25-32g of prepared rhizome of rehmannia, 8-10g of bretschneider pear pericarp, 10-12g of carthamus tinctorius, 8-10g of fragrant solomonseal rhizome, 10-12g of fossil fragment, 10-14g of curcuma roots, 18-22g of astragalus mongholicus, 26-32g of salvia miltiorrhiza, 8-10g of ginger and 26-30g of Chinese dates. Fumailing particles prepared from the traditional Chinese medicinal materials such as the ephedra, the aconite roots and the asarum herb are used for preventing and treating the slow arrhythmia; the materials are easy to obtain; the preparation method is simple; and the Fumailing capsule has a significant treatment effect on the arrhythmia, takes effect quickly, is safe to use and has no toxic or side effects, and can improve a sinoatrial node function and prevent and treat sinoatrial node hypofunction caused by various reasons.
Owner:SECOND AFFILIATED HOSPITAL OF COLLEGE OF MEDICINEOF XIAN JIAOTONG UNIV

Medicinal composition for treating ovary inflammation caused by tubercle bacillus affection

The invention relates to the field of reproductive medicine, in particular to a pharmaceutical composition for the treatment of oophoritis which is caused by tuberculosis infection. The pharmaceutical composition for the treatment of oophoritis which is caused by tuberculosis infection includes the components with the following parts by weight: 2 to 3 parts of sanchi and ginseng saponins Rb1, 2 to 4 parts of fructus forsythiae extract, 2 to 4 parts of pink herb extract and 1 to 2 parts of lalang grass rhizome extract. The invention is based on the pharmacological effects of improving blood rheology, expanding blood vessels, improving microcirculation and blood viscosity, regulating immune and so on of the drugs for promoting blood circulation and removing blood stasis, such as sanchi; the invention is combined with the effects of invigorating spleen, replenishing qi, removing stasis, smoothing circulation of blood, anti-inflammation and so on of lalang grass rhizome; the invention makes use of the effects of clearing heat, removing toxicity and better treating non-elimination tuberculosis of fructus forsythiae and the effects of anti-inflammatory and antibacterial of lalang grass rhizome, the pharmacological effects are definite, then the invention can gradually improve the environment of ovarian, the invention is proved that the invention can improve the blood viscosity and blood flow perfusion, so as to increase the weight of ovary, thicken the ovarian wall and narrow the tuberculosis focus, furthermore, the invention can not affect the ovarian functions and be conductive to pregnancy.
Owner:SOUTH CHINA UNIV OF TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products